Therefore, taken the SUMO1-conjugated PKM2 peptide identified from in vitro SUMOylation reaction as a target, we applied multiple reaction monitoring-based targeted MS (MRM-MS) to verify endogenous SUMOylation of PKM2 at K270 in leukemia cells. This evidence concerns the gene PKM and leukemia.